Abstract: A variety of signs and symptoms have been reported in regards to the typical and atypical presentations of CD. It is now well recognised that its onset may occur at any age and that atypical forms of CD are much more prevalent than its classic form (1). In this case, where the patient presented with high BMI and evidence of grade I of fatty liver disease, CD was suspected due to mildly abnormal bloating, cryptogenic hypertransaminasemia, abnormal LFT and poor response to fatty liver treatment. This presentation type is not uncommon; diagnosis was confi rmed by the presence of subtotal villous atrophy in the biopsy specimen, positive specifi c antibody screening (AGA, tTG and EMA antibodies), negative antibody screening and normalization of liver enzymes on a gluten-free diet (Tab. 2, Ref. 13). Full Text in PDF www.elis.sk.
Celiac disease (CD) is an enteropathy triggered by ingestion of gluten-containing grains in susceptible subjects. The etiology of CD is not fully understood but genetic and immunologic factors play an important role in the pathogenesis of this condition. Roughly 1 % (1 in 100) of the general population is thought to be affected by CD in Iran (1, 2) . Recent scientifi c data suggest that CD, as a multisystem autoimmune disorder, can also involve extraintestinal organs such as skin, pancreas, heart and liver (3) . This is a case report of a male adult who presented with oral aphthous ulcerations and fatty liver disease.
Case report
A 38-year-old male (healthy, BMI 28), was referred to a gastroenterology clinic due to his abnormal liver function test results (LFT) and recurrent oral aphthous ulcerations he had suffered from for the past six years. He had failed to respond to fatty liver treatment and his liver enzymes had not returned to normal after the treatment. He had no history of alcohol/drug abuse or hepatitis and presented with normal liver span; splenomegaly and K-F rings were not detected.
At the time of admission to the GI clinic, biochemical tests revealed lower levels of albumin and platelets compared to normal (Tab. 1). The patient did not suffer from iron defi ciency; levels of Ca, P, Mg, K, TG, Chl, FBS as well as serum levels of thyroidstimulating hormone (TSH) and free thyroxine (FT4) were within the normal range. While the patient had no history of viral hepatitis, an ultrasound scan of the liver revealed fatty liver disease, grade 1. The levels of urine copper (19 mg/24 h) and ceruloplasmin (18.5 mg/dl) were normal; furthermore, the patient presented with normal serology for HBV, HCV, ANA-ASMA and anti-LKM Ab. A liver biopsy was performed due to the abnormal LFT and the evidence of chronic liver disease; it showed focal architectural distortion of the liver parenchyma due to fi brosis and infi ltration of the fi brous tract containing dense lymphocytic infi ltration with diffuse periportal activities. Some plasma cells in the reticulum staining showed fi brous expansion of all portal tracts and frequent bridging fi brosis. The liver biopsy revealed grade II/stage 4 of chronic autoimmune hepatitis and could not confi rm fatty liver disease due to cryptogenic hypertransaminasemia. As the patient suffered from autoimmune liver disease and recurring aphthous ulcers, he underwent serological screening for celiac disease despite the absence of typical CD symptoms; human anti-tissue transglutaminase (tTG) antibodies, anti-endomysial antibodies (EMA) and anti-gliadin antibodies (AGA), IgAs, were positive. Endoscopic view of the duodenum showed scalloping of the duodenal folds.
(Scalloping, however, is not specifi c for CD and has been seen in other conditions such as eosinophilic GE, Giardiasis, amiloidosis, tropical sprue and HIV enteropathy). Four biopsy specimens were taken for pathological investigation. According to modifi ed Marsh classifi cation (4), the duodenal biopsy specimens showed subtotal villous atrophy with crypt hyperplasia and infi ltration of lamina propria with lymphocytes (Marsh IIIb), confi rming CD.
The patient was subsequently put on a gluten-free diet; after 12 months, liver enzymes were back to normal and serology revealed that the patient was anti-tTG and EMA-negative. On reintroduction of gluten food, LFT enzymes elevated quickly within one month (Tab. 2). Once the patient was taken off gluten food again, the liver enzyme levels normalized. Additionally to his gluten-free diet, folic acid, prednisolone and azathiopurine were introduced to supplement the treatment of his autoimmune hepatitis.
Discussion
Descriptive reports of liver histological features in celiac disease (CD) are sparse, and the effect of a gluten-free diet (GFD) on the course of liver disorders is poorly understood. Evidence suggests that the prevalence of CD may be considerably higher than previously thought; key factors in this development may be the increased awareness of subclinical, mildly symptomatic and asymptomatic presentations of this condition and its subsequent detection in patients (5) .
A variety of signs and symptoms have been reported in regards to the typical and atypical presentations of CD. It is now well recognised that its onset may occur at any age and that atypical forms of CD are much more prevalent than its classic form (1) .
In this case, where the patient presented with high BMI and evidence of grade I of fatty liver disease, CD was suspected due to mildly abnormal bloating, cryptogenic hypertransaminasemia, abnormal LFT and poor response to fatty liver treatment. This presentation type is not uncommon; diagnosis was confi rmed by the presence of subtotal villous atrophy in the biopsy specimen, positive specifi c antibody screening (AGA, tTG and EMA antibodies), negative antibody screening and normalization of liver enzymes on a gluten-free diet.
In previous studies, the prevalence of elevated transaminases in patients with CD was 36-55 % (6-8). Alavi-Moghaddam et al (2011) reported that 8.1 % of adult CD patients suffered from cryptogenic liver disorder (9) . Dicky et al (1995) identifi ed that 15 % of cases showed elevated levels of AST and ALT in their study (10) . In a large population of children with CD, Di Biase et al (2010) found that 40 % of CD patients had isolated hypertransaminasemia and 2 % had autoimmune liver hepatitis (11) . Volta et al (1998) found that of 55 patients with unexplained liver dysfunction, 5 had celiac disease (12) .
In similar cases with abnormal LFT above 100 (abnormal ALT & AST). Routine screening for CD is strongly recommended. As recently reported, cryptogenic and autoimmune hepatitis in patients with CD might represent distinct clinical, histological, and immunohistochemical entities, rather than two ends of a spectrum of liver injury (13) .
